CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to combat antibiotic resistance by developing new light-activated antimicrobial agents called Photoswitchable Amphiphilic Lipids (PALs). These compounds target bacterial membranes, which do not mutate, to selectively induce cell death, offering a novel strategy in the fight against resistant infection…
Antimicrobials have saved millions of lives since they were first discovered.
Unfortunately, today the world is facing up a global antibiotic resistance health emergency.
In fact, bacterial infections which have been susceptible to standard antibiotic regimes for decades are now becoming resistant to all major antimicrobial treatments, making their efficacy undermined.
Within this context, this proposal aims to develop a new and original strategy to combat antimicrobial resistance.
Photopharmaco…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
